Pfizer Inc (NYSE:PFE)

38.35
Delayed Data
As of Aug 03
 -0.125 / -0.32%
Today’s Change
27.88
Today|||52-Week Range
40.97
-2.11%
Year-to-Date
These Coronavirus Vaccine Makers Are Winning the Money Game So Far
Aug 01 / MotleyFool.com - Paid Partner Content
This Coronavirus Stock Just Got More Attractive: Should You Buy?
Jul 28 / MotleyFool.com - Paid Partner Content
5 Coronavirus Vaccines With Huge Operation Warp Speed Deals
Aug 01 / MotleyFool.com - Paid Partner Content
Got $2,000 in Cash? Put It Into This Company Testing for Coronavirus in Pro Sports
Jul 28 / MotleyFool.com - Paid Partner Content
Tech Giants Send Nasdaq Up 150+, but Coronavirus Vaccine Stocks Suffer on Gilead Earnings, Moderna Hack Attack
Jul 31 / MotleyFool.com - Paid Partner Content
Biotech Bonanza - Second Half Outlook
Jul 28 / Seeking Alpha - Paid Partner Content
5 Bargain Stocks With High Dividend Yields
Jul 31 / GuruFocus News - Paid Partner Content
Pfizer +3% on Q2 beat; raised midpoint of revenue guidance by $0.1B and non-GAAP EPS by $0.03
Jul 28 / Seeking Alpha - Paid Partner Content
Checkmate Pharmaceuticals Begins IPO Process
Jul 31 / Seeking Alpha - Paid Partner Content
Pfizer +3% after Q2 beat and stronger than expected full-year guidance
Jul 28 / Seeking Alpha - Paid Partner Content
Craving Healthcare: A Beginner's Guide And My 7 Picks
Jul 31 / Seeking Alpha - Paid Partner Content
Wall Street Breakfast: Negotiations Begin Over Next Coronavirus Relief Package
Jul 28 / Seeking Alpha - Paid Partner Content
Here's How to Build the Safest But Most Promising Coronavirus Portfolio
Jul 31 / MotleyFool.com - Paid Partner Content
Pfizer EPS beats by $0.12, beats on revenue
Jul 28 / Seeking Alpha - Paid Partner Content
Better Coronavirus Stock: BioNTech or GlaxoSmithKline?
Jul 31 / MotleyFool.com - Paid Partner Content
Pfizer, BioNTech Choose Coronavirus Vaccine Candidate to Advance to Phase 2/3 Trial
Jul 27 / MotleyFool.com - Paid Partner Content
Why Pfizer Could Be a Bigger Coronavirus Winner Than Moderna
Jul 31 / MotleyFool.com - Paid Partner Content
Pfizer, BioNTech rise as they start late-stage vaccine human trial
Jul 27 / Seeking Alpha - Paid Partner Content
Pfizer, BioNTech pledge 120M doses of COVID vaccine to Japan
Jul 31 / Seeking Alpha - Paid Partner Content
A Significant Market Shift To Value Stocks Is Bound To Happen
Jul 27 / Seeking Alpha - Paid Partner Content
Pfizer Covid-19 Vaccine Sales Could Hit $15 Billion
Jul 30 / GuruFocus News - Paid Partner Content
Pfizer Q2 2020 Earnings Preview
Jul 27 / Seeking Alpha - Paid Partner Content
Dividend Stock Purchases: Bert's June 2020 Summary
Jul 30 / Seeking Alpha - Paid Partner Content
Notable earnings before Tuesday's open
Jul 27 / Seeking Alpha - Paid Partner Content
Executive Orders on Pharmaceuticals Unlikely to Impact Industry, Investors
Jul 29 / GuruFocus News - Paid Partner Content
EU talks to procure COVID-19 supply stalled over financial issues
Jul 27 / Seeking Alpha - Paid Partner Content
Should Moderna Be Your Next Coronavirus Stock?
Jul 29 / MotleyFool.com - Paid Partner Content
Wide-Moat Stocks On Sale - The August 2020 Heat Map
Jul 27 / Seeking Alpha - Paid Partner Content
Pfizer And BioNTech Pick A Vaccine Candidate
Jul 29 / Seeking Alpha - Paid Partner Content
Moderna, Inc.: The Recent Pullback Is No Reason To Accumulate
Jul 27 / Seeking Alpha - Paid Partner Content
Wall Street Breakfast: Big Tech Before Congress
Jul 29 / Seeking Alpha - Paid Partner Content
2 Trading Mistakes for All Robinhood Investors to Avoid
Jul 27 / MotleyFool.com - Paid Partner Content
Pfizer (PFE) Q2 2020 Earnings Call Transcript
Jul 29 / MotleyFool.com - Paid Partner Content
Vanguard Health Care ETF: Outlook Remains Favorable Despite Higher Valuation
Jul 27 / Seeking Alpha - Paid Partner Content
The Race To Erase COVID-19
Jul 29 / Seeking Alpha - Paid Partner Content
Stalled US recovery leaves Congress no margin for error
Jul 27 / CNN.com - Paid Partner Content
Pfizer's (PFE) CEO Albert Bourla on Q2 2020 Results - Earnings Call Transcript
Jul 28 / Seeking Alpha - Paid Partner Content
Here's Your Guide to the Coronavirus Vaccine Leaders
Jul 26 / MotleyFool.com - Paid Partner Content
Moderna floating COVID-19 vaccine price up to $60 per course
Jul 28 / Seeking Alpha - Paid Partner Content
Is Johnson & Johnson an Underdog in the COVID-19 Vaccine Race?
Jul 26 / MotleyFool.com - Paid Partner Content
Pfizer Rises 4.5% on Q2 Beats, Raised Guidance
Jul 28 / MotleyFool.com - Paid Partner Content
5 Late-Stage COVID-19 Vaccines: Which Is Likely to Be the Biggest Winner?
Jul 26 / MotleyFool.com - Paid Partner Content
Pfizer to seek FDA emergency use nod for COVID-19 vaccine as early as October
Jul 28 / Seeking Alpha - Paid Partner Content
Is Moderna Stock a Buy?
Jul 26 / MotleyFool.com - Paid Partner Content
How Pfizer Beat Q2 Estimates Despite Upjohn Sales Plunging 31%
Jul 28 / MotleyFool.com - Paid Partner Content
Ex-Obama adviser warns of a potential repeat of the financial crisis
Jul 26 / CNN.com - Paid Partner Content
Pfizer/BioNTech COVID-19 Vaccine: A Reality Check
Jul 28 / Seeking Alpha - Paid Partner Content
The biggest tech earnings matter more than ever
Jul 26 / CNN.com - Paid Partner Content
Pfizer Inc. 2020 Q2 - Results - Earnings Call Presentation
Jul 28 / Seeking Alpha - Paid Partner Content
Dividend Champion And Contender Highlights: Week Of July 26
Jul 25 / Seeking Alpha - Paid Partner Content